Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Polymeric Nanoparticles for Drug Delivery in Glioblastoma: State of the Art and Future Perspectives Publisher Pubmed



Madani F1 ; Esnaashari SS2 ; Webster TJ3 ; Khosravani M1 ; Adabi M1, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Medical Nanotechnology, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  3. 3. School of Health Sciences and Biomedical Engineering, Hebei University of Technology, Tianjin, China
  4. 4. Food Microbiology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Controlled Release Published:2022


Abstract

Glioblastoma (GBM) is an aggressive, fatal and malignant primary brain tumor. Despite the current standard treatment for glioblastoma patients including neurosurgical resection, followed by concomitant radiation and chemotherapy, the median survival rate is only about 15 months. An unresolved challenge for current therapies is related to getting drugs through the blood-brain barrier (BBB), which hinders many chemotherapeutic agents from reaching tumors cells. Although a large amount of research has been done to circumvent the BBB and deliver drugs to the brain, with nanoparticles (NPs) taking the lead, the challenge is still high. In this regard, the BBB and how to transfer drug pathways through the BBB, especially using NPs, are introduced here. Afterwards, the latest advances in drug delivery, co-drug delivery, and combination modalities are described specifically for GBM treatments using natural and synthetic polymeric NPs and adjuvant therapies including hyperthermia, photodynamic therapy and also ketogenic regimens. In addition, receptor-mediated endocytosis agents that exist in endothelial capillary cells of the brain are explained. Lastly, future directions to finally deliver drugs through the BBB for GBM treatment are emphasized. It is the hope that this review can provide a number of practical pathways for the future development of BBB permeable nanochemotherapeutics against GBM. © 2022
Other Related Docs
10. Therapeutic Potentials of Curcumin in the Treatment of Glioblstoma, European Journal of Medicinal Chemistry (2020)
15. The Role of Ketogenic Diet in the Treatment of Neuroblastoma, Integrative Cancer Therapies (2023)
18. Rgd-Engineered Nanoparticles As an Innovative Drug Delivery System in Cancer Therapy, Journal of Drug Delivery Science and Technology (2023)
23. Nanoparticles: Novel Vehicles in Treatment of Glioblastoma, Biomedicine and Pharmacotherapy (2016)
25. Nanobased Cns Delivery Systems, Nanobiomaterials: Applications in Drug Delivery (2018)